ublic health value of universal HPV vaccination

Background: The story of Human Papillomavirus vaccination demands reflection not only for its public health impact on the prophylactic management of HPV disease, but also for its relevant economic and social outcomes. Greater than ever data confirm the efficacy and support the urge for effective vaccination plans for both genders before sexual debut. ∗ Corresponding author. E-mail addresses: raudisio@doctors.org.uk (R.A. Audisio), icardi@unige.it (G. Icardi), andrea.isidori@uniroma1.it (A.M. Isidori), dr.carlo.liverani@gmail.com (C.A. Liverani), lberto.lombardi@lorenzinifoundation.org (A. Lombardi), luciorm55@gmail.com (L. Mariani), f.mennini@uniroma2.it (F.S. Mennini), avid.mitchell2@bthft.nhs.uk (D.A. Mitchell), andrea.peracino@lorenzinifoundation.org (A. Peracino), sergiopecos@gmail.com (S. Pecorelli), giovanni.rezza@iss.it (G. Rezza), arlo.signorelli@unipr.it (C. Signorelli), giovannivitalirosati@gmail.com (G.V. Rosati), gianvincenzo.zuccotti@unimi.it (G.V. Zuccotti). ttp://dx.doi.org/10.1016/j.critrevonc.2015.07.015 040-8428/© 2015 Published by Elsevier Ireland Ltd. ARTICLE IN PRESS G Model ONCH-2017; No. of Pages 11 2 R.A. Audisio et al. / Critical Reviews in Oncology/Hematology xxx (2015) xxx–xxx